India Globalization Capital (NYSE MKT: IGC), an innovator in developing cannabis-based combination therapies to treat pain and other conditions, is currently applying the revolutionary seizure-treating potential of CBD to another population: domestic pets, and the company is addressing the 5 percent of dogs and just over 2 percent of cats in the United States that experience seizures.
Bitcoin’s recent climb above the $4,500 mark is just one example of how its market capitalization continues to gain unprecedented reach. (http://nnw.fm/lGp8V) From cannabis to technology, bitcoin has impacted industries far and wide, but analysts believe that the cryptocurrency isn’t done climbing.
Marijuana use is currently illegal in China, but cannabis-based oils, including hemp-based CBD, are legal, giving CIIX access to a market of almost two billion potential customers in that country.
IGC has filed two patents, IGC-502 and IGC-505, for combination therapies for the treatment of seizures in dogs and cats, which in it itself is a surprisingly large market.
The nutraceutical industry boasts a diversified playing field, and Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is taking a unique approach to this burgeoning market, focusing on the development of proprietary research and products that combine the health benefits of botanical oils derived from cannabis and algae.
ChineseInvestors.com (OTCQB: CIIX) is a leading financial information website for Chinese-speaking investors in the United States and China.
ChineseInvestors.com, Inc. (OTCQB: CIIX) has been closely monitored for its upside as it competes in the hemp-derived cannabis market. CIIX has launched a cannabidiol (CBD) online store in the free-trade zone of Shanghai and soon it plans to open a brick-and-mortar store in its home market of San Gabriel, California, to market a line of food and nutrition products.
Combination therapies that use cannabis-based pain reduction methods without the negative side effects of opioids are looking to be a positive growth opportunity among specialty pharmaceuticals, particularly for postoperative and chronic pain relief.
Algae Dynamics Corp. (OTCQB: ADYNF) is uniquely positioned to take advantage of the full legalization of cannabis in Canada by leveraging its expertise and experience with algae oil extraction to expand into the Canadian cannabis oil marketplace.
The strategy by ChineseInvestors.com, Inc. (OTCQB: CIIX) to open the first cannabidiol (CBD) online retail store in China, and to use a wholly-owned subsidiary in the retail and wholesale business to supply CBD health oil products throughout Asia, has attracted the attention of investors who have seen global activity in the cannabis market grow.
Everyone knows there is money to be made in marijuana these days. Americans already spend more on cannabis than ice cream each year, and Canadians are anticipating a combined market that may be larger than the entire domestic alcohol industry by 2020.
China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy.
With an annual growth rate of nearly 60 percent, CBD oil has become one of the fastest-growing market categories in the country. U.S.-based ChineseInvestors.com, Inc. (OTCQB: CIIX) is set to capitalize on this meteoric growth.
ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research.
Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC)
